Unlocking market insights: Bridging data gaps to inform Phase 3 trial strategy and beyond

Clinical landscaping for strategic market positioning.

The brief

Our client sought to evaluate the global market potential for a drug currently in Phase 2 of clinical testing. This evaluation needed to encompass disease epidemiology and a detailed assessment of Key Opinion Leader (KOL), competitive and pricing landscapes. The objective was to shape their Phase 3 trial strategy and gain insight into future prospects.  

The challenge

In order to build an optimal Phase 3 trial strategy our client required a comprehensive clinical landscape assessment. A data gap meant they lacked vital information on disease prevalence and key risk factors.  

Solution

We delivered a bespoke intelligence board that provided a comprehensive overview of available epidemiology data, alongside outputs from an opinion leader mapping exercise, a competitive analysis, a price benchmarking assessment, and digital and social listening. This multi-faceted solution ultimately offered our client valuable insights into market opportunities.

  • By performing a systematic literature review and publication landscaping exercise, we were able to extract data on incidence, prevalence and risk factors across target markets. This epidemiology data was housed in its own interactive dashboard, alongside a pricing and market share analysis. The dashboard was thoughtfully designed to allow flexible filtering by variables of interest to our client.  
  • A comprehensive treatment landscape report provided our client with valuable insight into the burden of disease and unmet needs within the therapy area.  
  • We also performed an exhaustive competitor analysis that included assessment of competitor clinical trial designs and overall activity within the therapy area. Through the integration of social and digital listening, we actively monitored adverse events associated with competitor treatments.  
  • Last, we conducted a KOL mapping exercise to identify influential figures, working to inform our client’s future engagement strategies.

Value to the client

Rapid and comprehensive clinical insights coupled with VISFO’s strategic recommendations not only armed our client with the information they needed to inform their immediate trial strategy, but also allowed them to plan how to strategically position themselves in the future market landscape.

Want to work with us?

We would love to hear from you!

Get in touch.